Contents
Download PDF
pdf Download XML
560 Views
130 Downloads
Share this article
Research Article | Volume 13 Issue:1 (, 2023) | Pages 100 - 106
Outcome of Injection Sclerotherapy Using Absolute Alcohol in Patients with Esophageal Varices
Under a Creative Commons license
Open Access
DOI : 10.5083/ejcm
Published
Jan. 20, 2023
Abstract

Introduction:Lower end of the esophagus portosystemic anastomosis formed by Left gastric vein and Esophageal tributaries of accessory hemizygous vein. Although all these vessels contribute to the shunting of esophageal collaterals or varices, are the most important clinically, because of their predilection to bleeding. Sclerotherapy is associated with a wide range of complications ranging from transient pyrexia to esophageal perforation resulting in death. Complications following sclerotherapy depends on a number of factors namely nature of sclerosant used, amount of sclerosant, injection site, concentration of the drug and the time interval between the sessions. Material And Methods: A prospective and observation study on management of esophageal varices by endoscopic injection sclerotherapy using absolute alcohol as sclerosant has been done in Endoscopy Unit.

Keywords
Recommended Articles
Research Article
To assess the effectiveness of using either single extra-articular humerus plating or bipillar plating for treating distal humerus fractures in a tertiary care teaching hospital
Published: 22/09/2013
Download PDF
Research Article
A Prospective Study to Evaluate the Microbiological Profile and Fungal Culture Positivity in Perforation Peritonitis
Published: 15/10/2025
Download PDF
Research Article
Association between apolipoproteins and coronary artery disease (CAD), a case–control observational study
Published: 01/05/2020
Download PDF
Research Article
Evaluation of Quality of Life and Treatment Response Following Quad Shot Radiotherapy in Patients with Locally Advanced or Metastatic Head and Neck Cancer
Published: 14/03/2022
Download PDF
Chat on WhatsApp
Copyright © EJCM Publisher. All Rights Reserved.